The PennZone

CHADDS FORD, Pa., Aug. 28, 2024 ~ ClariMed, Inc., a renowned company known for its human-centered approach to medical device development and regulatory services, has recently announced the opening of its new office in Leeds, UK. This move is part of the company's global expansion strategy and aims to strengthen its presence in Europe while taking advantage of the region's thriving healthcare innovation ecosystem.

The new Leeds office will serve as a hub for ClariMed's expanding medical device user research capabilities. With access to a diverse pool of study participants, the company will be able to enhance its human factors engineering insights. Additionally, being in close proximity to world-class healthcare institutions and professionals will provide valuable opportunities for collaboration and innovation in user-centered design.

Kelley Kendle, CEO of ClariMed, expressed her excitement about this milestone in the company's growth. "This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit," she said. Kendle believes that Leeds' strategic location and thriving healthcare sector align perfectly with ClariMed's mission to drive human-centered innovation in medical device development.

More on The PennZone

• First Generation and TechniCom Leadership Appointments Usher in a Bright Future
• Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
• GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
• Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
• What are the signs of an AC refrigerant leak?

Julian Dixon, Associate Director of Human Factors and Site Lead of the Cambridge, UK office, highlighted how this expansion showcases ClariMed's commitment to excellence and unique company culture. "The Leeds office will enable us to further diversify our participant base and recruit top talent from across Northern England," Dixon stated. He believes that this enhanced capability will result in more comprehensive insights for clients, ultimately leading to safer and more effective medical devices.

Jessica Köhne, Site Lead for the new Leeds office, emphasized the strategic importance of this location. "Leeds is at the heart of the UK's health innovation," she said. "Our new office is strategically positioned to leverage the city's world-class universities, research institutions, and the Leeds Innovation District." Köhne believes that this location will allow them to form stronger partnerships with local healthcare providers and tech innovators, bringing fresh perspectives to their human factors research and further enhancing their ability to deliver impactful human-centered insights. She also expressed excitement about contributing to the region's growing reputation as a hub for medical device innovation while expanding ClariMed's capabilities to serve their global client base.

More on The PennZone

• The Blue Luna Encourages Local Schools to Take Steps to Enhance Safety for Students and Staff
• Philadelphia Homeowners Now Have a Faster Way to Sell Their House Without Agents or Repairs
• The Sessions Studios Secures $300 Million Commitment to Launch World-Class Studio and 15-Film Global Slate
• Smart Resnse Unveils Smart Resnse(SRMS) Token-Powered AI Orchestration Platform to Revolutionize Multi-Billion Dollar Market
• Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request

This strategic expansion aligns with ClariMed's vision to become the worldwide leader in human-centered regulatory and development services for medical products. By establishing a presence in Leeds, the company reinforces its commitment to driving meaningful advancements in healthcare and shaping a future where innovative, user-friendly medical devices are accessible to all. With this new office, ClariMed is well-positioned to continue its mission of putting people at the center of medical device development and regulation.

---

Show All News | Report Violation